Cancer Therapeutics (CT) Program
The goal of the Cancer Therapeutics (CT) Program is to foster the development of novel therapeutic, chemopreventive and biomarker strategies that can be translated into more effective clinical applications through proof-of-principle, early-phase clinical and correlative science studies.
The thematic areas and specific aims of the CT Program are:
- Drug Development and Delivery: To foster the development and enhanced delivery of new therapeutic and preventive agents.
- Biomarkers: To promote discovery and utilization of biomarkers that can be used for diagnosis, prognosis and prediction of response.
- Developmental Therapeutics: To design and conduct innovative early-phase clinical trials integrated with correlative science studies.
- Lacey McNally, PhD Program Co-Leader
-
Kathleen Moore, MD
Program Co-Leader (Interim)
Explore Supportive Care services for your cancer journey
Learn More
Find out how you may qualify to enroll in a cancer clinical trial
Learn More
Find out if you’re at risk for diabetes
Learn More
See what our commitment to ending diabetes in this century means for you
Learn More
-
OU Wastewater Surveillance Team to Monitor Long-Term for Foodborne Pathogens, a Global First
With the onset of the COVID-19 pandemic, wastewater surveillance in Oklahoma became an important tool for predicting surges and clusters of ...
Read More -
Meet Cooper - Kids Club Member
Name: Cooper Bray Hometown: Ratliff City Age: 5 Cooper Bray is one of our youngest and first Kids Club members. His dad, Steven, helped share a little ...
Read More -
University of Oklahoma Fran and Earl Ziegler College of Nursing Expands Nursing Education Program ...
The University of Oklahoma Board of Regents and the Oklahoma Board of Nursing have approved expansion of nursing education programs through the Fran ...
Read More